Nalaganje...
Somatostatin analog therapy for severe polycystic liver disease: results after 2 years
BACKGROUND: We showed in a randomized double-blinded placebo-controlled clinical trial that octreotide long-acting repeatable depot.® (OctLAR(®)) for 12 months reduces kidney and liver growth in autosomal dominant polycystic kidney patients with severe polycystic liver disease (PLD) and liver growth...
Shranjeno v:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Oxford University Press
2012
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3433774/ https://ncbi.nlm.nih.gov/pubmed/22773240 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfs152 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|